Mexican antitrust agency says generic drug market needs reform to boost competition
MLex Summary: The Mexican antitrust authority said in a report that the generic drug market in the country needs reform to become more competitive. The Federal Economic Competition Commission, or Cofece, concluded that regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article